Insights On CONTRACT PHARMA MANUFACTURING

  1. Sustainability By Design In API Manufacturing 7/29/2025

    Explore the urgent need for sustainability in small molecule API manufacturing, as well as reveal regulatory drivers, green chemistry innovations, and practical strategies to reduce emissions.

  2. From IND To NDA: The Role Of The Kilo Lab In A Seamless Scaleup 7/29/2025

    To derisk your manufacturing, work with an outsourcing partner that prioritizes the kilo lab as a space to develop a proven, robust, and reliable workflow from clinical to commercial scale.

  3. Upperton Pharma Solutions Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

    Ian Lafferty, CTO, and Josh Moule, Business Development Manager, talk through Upperton’s capabilities, project management approach and provide a virtual tour of their 60,000 sq. ft development and manufacturing facility.

  4. Quotient Sciences Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

    Compressed timelines pose challenges, ranging from limited API supply to clinical trial logistics. Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.

  5. PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

    Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.

  6. Your Boutique CDMO Partner Of Choice 7/29/2025

    Lora Wallis and Chris Cuthbertson highlight Douglas CDMO’s strengths in high-potency softgels and liquids and the company's 67 years of expertise and a client-centric approach.

  7. Comprehensive CDMO Services From Clinical To Commercial Supply 7/29/2025

    Bora Pharmaceuticals specializes in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, and sterile injectable products.

  8. MilliporeSigma Capacity Update July 2025: Small Molecule Drug Substance/API 7/29/2025

    Applications specialist John Stevens shows how MilliporeSigma is using their 35+ years of CDMO experience and expertise to move customers’ small molecules forward to the clinic and beyond to commercialization.

  9. Building Digital Capabilities For An Intelligent Tomorrow 7/29/2025

    Explore how modern manufacturing software is transforming operations with AI-driven insights to empower CDMOs and CMOs to boost efficiency, agility, and client satisfaction in a competitive landscape.

  10. Leveraging Technology For Rapid Clinical Material Delivery 7/29/2025

    Discover how one family's collaboration with a specialized CDMO enabled the rapid development of a life-saving gene therapy for their daughter diagnosed with an ultra-rare disease.